Capsa Healthcare acquires pharmacy automation solutions provider RoboPharma

Capsa Healthcare, a portfolio company of Levine Leichtman Capital Partners (LLCP), has acquired NewRobo Development and subsidiaries (collectively, RoboPharma), based in Netherlands, which creates and implements pharmacy automation solutions for European pharmacies.

RoboPharma is said to be expanding its technology in Europe, Australasia, and Africa. The company is engaged in designing and installation of user-friendly pharmacy automation systems for delivering speed, reliability, simplicity, and maximizing the space available.

Its products are said to include the complete variety for high-speed, high-efficiency prescription fulfillment, in addition to software that interfaces to all the leading external pharmacy systems, logistics solutions, and central fill build-outs.

Based in Oregon, Capsa Healthcare offers engineered workflow products that boost efficiency and lower costs, improve medication security, and tighten inventory control across healthcare settings across the world.

Frank van der Vaart – owner and CEO of RoboPharma said: “In Capsa and LLCP, we’ve found both the partner and financial sponsor to help us take RoboPharma to the next level. We’re excited about what this combination can create, as Capsa offers RoboPharma strategic support to accelerate our growth plans in Europe and the United States.”

The core offerings of Capsa Healthcare include mobile workstations, pharmacy automation products, and medication management solutions sold to more than 3,000 end customers, which include major health systems, senior care communities, and leading retail and institutional pharmacies.

Avi Zisman – CEO of Capsa Healthcare said: “RoboPharma’s market leading products, people, and reputation make it a perfect addition to the Capsa platform. This partnership extends Capsa’s pharmacy automation product portfolio, enhances our engineering and support capabilities, and expands our geographic presence in Europe.”